{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:29:27Z","timestamp":1792798167771,"version":"4.5.0"},"reference-count":38,"publisher":"American Society of Hematology","issue":"2","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2009,1,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>No validated biomarkers exist for acute graft-versus-host disease (GVHD). We screened plasma with antibody microarrays for 120 proteins in a discovery set of 42 patients who underwent transplantation that revealed 8 potential biomarkers for diagnostic of GVHD. We then measured by enzyme-linked immunosorbent assay (ELISA) the levels of these biomarkers in samples from 424 patients who underwent transplantation randomly divided into training (n = 282) and validation (n = 142) sets. Logistic regression analysis of these 8 proteins determined a composite biomarker panel of 4 proteins (interleukin-2-receptor-alpha, tumor-necrosis-factor-receptor-1, interleukin-8, and hepatocyte growth factor) that optimally discriminated patients with and without GVHD. The area under the receiver operating characteristic curve distinguishing these 2 groups in the training set was 0.91 (95% confidence interval, 0.87\u20130.94) and 0.86 (95% confidence interval, 0.79\u20130.92) in the validation set. In patients with GVHD, Cox regression analysis revealed that the biomarker panel predicted survival independently of GVHD severity. A panel of 4 biomarkers can confirm the diagnosis of GVHD in patients at onset of clinical symptoms of GVHD and provide prognostic information independent of GVHD severity.<\/jats:p>","DOI":"10.1182\/blood-2008-07-167098","type":"journal-article","created":{"date-parts":[[2008,10,2]],"date-time":"2008-10-02T20:44:52Z","timestamp":1222980292000},"page":"273-278","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":341,"title":["A biomarker panel for acute graft-versus-host disease"],"prefix":"10.1182","volume":"113","author":[{"given":"Sophie","family":"Paczesny","sequence":"first","affiliation":[{"name":"Department of Pediatrics, University of Michigan, Ann Arbor;"},{"name":"Fred Hutchinson Cancer Research Center, Seattle, WA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oleg I.","family":"Krijanovski","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"Braun","sequence":"additional","affiliation":[{"name":"Department of Biostatistics,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung W.","family":"Choi","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Michigan, Ann Arbor;"},{"name":"Department of Internal Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawn G.","family":"Clouthier","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Michigan, Ann Arbor;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rork","family":"Kuick","sequence":"additional","affiliation":[{"name":"Comprehensive Cancer Center Biostatistics Core, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Misek","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Michigan, Ann Arbor; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth R.","family":"Cooke","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Case Western Reserve University, Cleveland, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carrie L.","family":"Kitko","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Michigan, Ann Arbor;"},{"name":"Department of Internal Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Weyand","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Michigan, Ann Arbor;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Bickley","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Michigan, Ann Arbor;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn","family":"Jones","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Michigan, Ann Arbor;"},{"name":"Department of Internal Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Whitfield","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Michigan, Ann Arbor;"},{"name":"Department of Internal Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavan","family":"Reddy","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John E.","family":"Levine","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Michigan, Ann Arbor;"},{"name":"Department of Internal Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir M.","family":"Hanash","sequence":"additional","affiliation":[{"name":"Fred Hutchinson Cancer Research Center, Seattle, WA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James L. M.","family":"Ferrara","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Michigan, Ann Arbor;"},{"name":"Department of Internal Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111714471971400_B1","first-page":"825","article-title":"1994 Consensus Conference on Acute GVHD Grading.","volume":"15","author":"Przepiorka","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"2019111714471971400_B2","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1182\/blood.V77.8.1821.1821","article-title":"A retrospective analysis of therapy for acute graft-versus-host disease: secondary treatment.","volume":"77","author":"Martin","year":"1991","journal-title":"Blood"},{"key":"2019111714471971400_B3","first-page":"185","article-title":"Serum concentration of the soluble interleukin-2 receptor for monitoring acute graft-versus-host disease.","volume":"17","author":"Miyamoto","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"2019111714471971400_B4","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/sj.bmt.1701041","article-title":"Soluble interleukin-2 receptor serum levels after allogeneic bone marrow transplantations as a marker for GVHD.","volume":"21","author":"Grimm","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"2019111714471971400_B5","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/sj.bmt.1701163","article-title":"Monitoring soluble interleukin-2 receptor levels in related and unrelated donor allogenic bone marrow transplantation.","volume":"21","author":"Foley","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"2019111714471971400_B6","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1067\/mai.2000.106774","article-title":"Serum levels of soluble IL-2 receptor, IL-12, IL-18, and IFN-gamma in patients with acute graft-versus-host disease after allogeneic bone marrow transplantation.","volume":"106","author":"Nakamura","year":"2000","journal-title":"J Allergy Clin Immunol"},{"key":"2019111714471971400_B7","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.trim.2005.10.002","article-title":"Effect of IL-18 and sIL2R on aGVHD occurrence after hematopoietic stem cell transplantation in some Iranian patients.","volume":"15","author":"Shaiegan","year":"2006","journal-title":"Transpl Immunol"},{"key":"2019111714471971400_B8","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/S0301-472X(03)00264-9","article-title":"Serum cytokine levels and acute graft-versus-host disease after HLA-identical hematopoietic stem cell transplantation.","volume":"31","author":"Visentainer","year":"2003","journal-title":"Exp Hematol"},{"key":"2019111714471971400_B9","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1182\/blood.V75.4.1011.1011","article-title":"Increased serum levels of tumor necrosis factor alpha precede major complications of bone marrow transplantation.","volume":"75","author":"Holler","year":"1990","journal-title":"Blood"},{"key":"2019111714471971400_B10","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1067\/mai.2000.106060","article-title":"Serum markers of graft-versus-host disease after bone marrow transplantation.","volume":"106","author":"Kayaba","year":"2000","journal-title":"J Allergy Clin Immunol"},{"key":"2019111714471971400_B11","first-page":"243","article-title":"Soluble tumor necrosis factor (sTNF) receptors: a possible prognostic marker for bone marrow transplantation-related complications.","volume":"2","author":"Or","year":"1996","journal-title":"Cytokines Mol Ther"},{"key":"2019111714471971400_B12","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/sj.bmt.1703095","article-title":"Increased hepatocyte growth factor in serum in acute graft-versus-host disease.","volume":"28","author":"Okamoto","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"2019111714471971400_B13","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1038\/sj.leu.2402946","article-title":"Proinflammatory cytokines and their role in the development of major transplant-related complications in the early phase after allogeneic bone marrow transplantation.","volume":"17","author":"Schots","year":"2003","journal-title":"Leukemia"},{"key":"2019111714471971400_B14","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1182\/blood.V81.9.2252.2252","article-title":"Elevated interleukin-8 serum concentrations in beta-thalassemia and graft-versus-host disease.","volume":"81","author":"Uguccioni","year":"1993","journal-title":"Blood"},{"key":"2019111714471971400_B15","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1097\/00007890-199810150-00009","article-title":"Serum cytokine levels after HLA-identical bone marrow transplantation.","volume":"66","author":"Liem","year":"1998","journal-title":"Transplantation"},{"key":"2019111714471971400_B16","first-page":"745","article-title":"Serum cytokine levels in bone marrow transplantation: synergistic interaction of interleukin-6, interferon-gamma, and tumor necrosis factor-alpha in graft-versus-host disease.","volume":"13","author":"Imamura","year":"1994","journal-title":"Bone Marrow Transplant"},{"key":"2019111714471971400_B17","doi-asserted-by":"crossref","first-page":"4407","DOI":"10.1182\/blood-2005-07-2919","article-title":"Inflammatory cytokines and acute graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation.","volume":"106","author":"Mohty","year":"2005","journal-title":"Blood"},{"key":"2019111714471971400_B18","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1046\/j.1365-2141.2000.02095.x","article-title":"Elevated interleukin (IL)-18 levels during acute graft-versus-host disease after allogeneic bone marrow transplantation.","volume":"109","author":"Fujimori","year":"2000","journal-title":"Br J Haematol"},{"key":"2019111714471971400_B19","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1097\/00007890-199009000-00033","article-title":"Serum tumor necrosis factor alpha associated with acute graft-versus-host disease in humans.","volume":"50","author":"Symington","year":"1990","journal-title":"Transplantation"},{"key":"2019111714471971400_B20","doi-asserted-by":"crossref","first-page":"4535","DOI":"10.1182\/blood-2006-10-049817","article-title":"Serum cytokeratin-18 fragments as quantitative markers of epithelial apoptosis in liver and intestinal graft-versus-host disease.","volume":"110","author":"Luft","year":"2007","journal-title":"Blood"},{"key":"2019111714471971400_B21","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1182\/blood-2006-12-061408","article-title":"CXCL10-CXCR3 interactions play an important role in the pathogenesis of acute graft-versus-host disease in the skin following allogeneic stem cell transplantation.","volume":"110","author":"Piper","year":"2007","journal-title":"Blood"},{"key":"2019111714471971400_B22","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/01.TP.0000074316.76104.A5","article-title":"Increased levels of syndecan-1 in serum during acute graft-versus-host disease.","volume":"76","author":"Seidel","year":"2003","journal-title":"Transplantation"},{"key":"2019111714471971400_B23","doi-asserted-by":"crossref","first-page":"4403","DOI":"10.1182\/blood-2007-06-097287","article-title":"CCL8 is a potential molecular candidate for the diagnosis of graft-versus-host disease.","volume":"111","author":"Hori","year":"2008","journal-title":"Blood"},{"key":"2019111714471971400_B24","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1182\/blood-2004-02-0518","article-title":"Proteomics applied to the clinical follow-up of patients after allogeneic hematopoietic stem cell transplantation.","volume":"104","author":"Kaiser","year":"2004","journal-title":"Blood"},{"key":"2019111714471971400_B25","doi-asserted-by":"crossref","first-page":"5511","DOI":"10.1182\/blood-2007-01-069757","article-title":"Proteomic patterns predict acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.","volume":"109","author":"Weissinger","year":"2007","journal-title":"Blood"},{"key":"2019111714471971400_B26","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.exphem.2006.02.013","article-title":"Accurate diagnosis of acute graft-versus-host disease using serum proteomic pattern analysis.","volume":"34","author":"Srinivasan","year":"2006","journal-title":"Exp Hematol"},{"key":"2019111714471971400_B27","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1074\/mcp.M400126-MCP200","article-title":"Intact-protein-based high-resolution three-dimensional quantitative analysis system for proteome profiling of biological fluids.","volume":"4","author":"Wang","year":"2005","journal-title":"Mol Cell Proteomics"},{"key":"2019111714471971400_B28","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jim.2005.04.012","article-title":"Sequential ELISA to profile multiple cytokines from small volumes.","volume":"302","author":"Osuchowski","year":"2005","journal-title":"J Immunol Methods"},{"key":"2019111714471971400_B29","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the sub-distribution of a competing risk.","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"key":"2019111714471971400_B30","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1572-0241.2005.40819.x","article-title":"Protein microarray analysis of disease activity in pediatric inflammatory bowel disease demonstrates elevated serum PLGF, IL-7, TGF-beta1, and IL-12p40 levels in Crohn's disease and ulcerative colitis patients in remission versus active disease.","volume":"100","author":"Kader","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"2019111714471971400_B31","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1089\/omi.2006.10.411","article-title":"Antibody microarrays: current status and key technological advances.","volume":"10","author":"Wingren","year":"2006","journal-title":"Omics"},{"key":"2019111714471971400_B32","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1056\/NEJM199103073241005","article-title":"Graft-versus-host disease.","volume":"324","author":"Ferrara","year":"1991","journal-title":"N Engl J Med"},{"key":"2019111714471971400_B33","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1053\/j.seminhematol.2005.09.001","article-title":"Pathophysiology of graft-versus-host disease.","volume":"43","author":"Ferrara","year":"2006","journal-title":"Semin Hematol"},{"key":"2019111714471971400_B34","first-page":"427","article-title":"Prophylaxis and treatment of acute graft-vs.-host disease.","volume-title":"Graft-vs-Host Disease","author":"Bierer","year":"2005","edition":"3rd ed."},{"key":"2019111714471971400_B35","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0268-960X(03)00009-2","article-title":"Immunobiology of acute graft-versus-host disease.","volume":"17","author":"Reddy","year":"2003","journal-title":"Blood Rev"},{"key":"2019111714471971400_B36","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1182\/blood-2007-09-112987","article-title":"Etanercept plus methylprednisolone as initial therapy for acute GVHD.","volume":"111","author":"Levine","year":"2008","journal-title":"Blood"},{"key":"2019111714471971400_B37","first-page":"125","article-title":"Chemokines and graft-vs.-host-disease.","volume-title":"Graft-vs-Host Disease","author":"Cooke","year":"2005","edition":"3rd ed."},{"key":"2019111714471971400_B38","doi-asserted-by":"crossref","article-title":"The impact of soluble tumor necrosis factor receptor: etanercept on the treatment of idiopathic pneumonia syndrome following allogeneic hematopoietic stem cell transplantation.","author":"Yanik","DOI":"10.1182\/blood-2008-03-143412"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/113\/2\/273\/1455650\/zh800209000273.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/113\/2\/273\/1455650\/zh800209000273.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,17]],"date-time":"2019-11-17T14:47:36Z","timestamp":1574002056000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/113\/2\/273\/24694\/A-biomarker-panel-for-acute-graftversushost"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,8]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,1,8]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2008-07-167098","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1144983.622417","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.1144983.602145","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.1144983.602090","asserted-by":"object"}]},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1,8]]}}}